BACKGROUND: Coronavirus disease-19 (COVID-19) has been declared a world pandemic by World Health Organization (WHO). The ability of COVID-19 to be transmitted quickly causes fear and excessive worry in certain groups of people, such as the elderly and those with chronic diseases, including oncology and gynecology patients and the caregivers around them (family members). AIM: This study investigates knowledge, attitude, and negative emotions among gynecologic oncology patients and their families during the COVID-19 pandemic at Hasan Sadikin Public Hospital. METHODS: In this descriptive study, 100 patients with gynecologic malignancies at Hasan Sadikin Hospital, Bandung, Indonesia, were assessed in May 2020–April 2020, who asked for their current knowledge, attitude, as well as negative emotions through Depression Anxiety Stress Scale (DASS-42). RESULTS: The average age of the respondents in this study was 45.50. There were 31 respondents with low-level knowledge, 36 with moderate-level knowledge, and 33 with a high level of knowledge about COVID-19. Based on the attitude assessment, only 44 respondents (44%) always wore masks, 54 (54%) kept a distance of 1 meter, and 42 (42%) kept away from the crowd. An evaluation using the DASS-42 showed that 3, 4, and 0 subjects experienced severe depression, severe anxiety, and severe stress, respectively. CONCLUSIONS: All Indonesian citizens must take necessary measures to prevent COVID-19, including wearing masks, maintaining a minimum distance of 1 m, and washing hands. This study found that not all respondents could comply with the health protocols that were carried out to prevent the transmission of COVID-19. Respondents who experienced severe depression and severe anxiety needed further attention to determine whether they required counseling with a psychiatrist.
Patient: Female, 19-year-old Final Diagnosis: Gestational thropoblastic neoplasia Symptoms: Bleeding Medication:— Clinical Procedure: Curettage Specialty: Obstetrics and Gynecology • Oncology Objective: Rare disease Background: Gestational trophoblastic disease (GTD) encompasses a group of disorders that arise from abnormal growth of trophoblastic tissue. The spectrum of GTD includes 2 major groups: benign and malignant. The benign form is a hydatidiform mole, either complete or partial; the malignant forms, referred to as gestational trophoblastic neoplasia (GTN), consist of invasive moles, choriocarcinomas, placental site trophoblastic tumors, and epithelioid trophoblastic tumors. Most patients who undergo evacuation of a hydatidiform mole by curettage have a disease-free period before a new tumor develops that can be considered malignant. In rare cases, metastasis occurs rapidly and manifests coincidentally before the hydatidiform mole can be evacuated. Case Report: A 19-year-old woman in Bandung City, West Java, Indonesia, was diagnosed with a molar pregnancy with early evidence of a mass in her vagina that was suspicious for stage II GTN. The early emergence of a vaginal mass was a rare case of early transformation of a molar pregnancy into GTN. Conclusions: Careful evaluation is warranted of patients with characteristics typical of an intrauterine molar pregnancy who have an early presentation of a vaginal mass because of the possibility that the diagnosis could be GTN.
Tujuan: Untuk mengetahui gambaran karakteristik klinis dan histopatologi kanker ovarium anak di RSUP Dr. Hasan Sadikin Bandung. Metode: Penelitian ini menggunakan desain penelitian deskriptif. Data dikumpulkan dari rekam medis pasien kanker ovarium anak di RSUP Dr. Hasan Sadikin Bandung tahun 2017–2020. Hasil: Terdapat 22 pasien kanker ovarium anak yang sesuai dengan kriteria inklusi dan eksklusi. Ditemukan pasien kanker ovarium anak paling banyak usia 13–18 tahun sebanyak 13 orang (59,1%), stadium klinis I sebanyak 10 orang (45,4%), histopatologi jenis sel germinal sebanyak 17 orang (77%), dan gejala klinis benjolan pada perut sebanyak 16 orang (33%). Kesimpulan: Kanker ovarium anak di RSUP Dr. Hasan Sadikin Bandung Bandung periode 1 Januari 2017 – 31 Desember 2020 paling sering terjadi pada pasien dengan rentang usia 13–18 tahun, terdiagnosis pada stadium I, karakteristik histopatologi tipe sel germinal, dan memiliki gejala klinis berupa benjolan pada perut. Overview of Clinical Characteristics and Histopathology of Pediatric Ovarian Cancer at RSUP Dr. Hasan Sadikin Bandung Abstract Objective: To determine pediatric ovarian cancer’s clinical characteristics and histopathology at RSUP Dr. Hasan Sadikin Bandung. Methods: This study used a descriptive research design. Data were collected from medical records of pediatric ovarian cancer patients at RSUP Dr. Hasan Sadikin Bandung in 2017 – 2020. Result: 22 pediatric ovarian cancer patients met the inclusion and exclusion criteria. The majority of pediatric ovarian cancer patients were in the age 13-18 years as many as 13 people (59.1%), clinical stage I characteristics as many as 10 people (45.4%), histopathological of germ cell types as many as 17 people (77%), and clinical symptoms as lumps in the abdomen as many as 16 people (33%). Conclusion: Pediatric ovarian cancer at RSUP Dr. Hasan Sadikin Bandung period 1 January 2017 – 31 December 2020 most often occurred in patients aged 13–18 years, diagnosed at stage I, histopathological characteristics of germ cell type, and had clinical symptoms in the form of abdominal lump. Key words: Ovary, Pediatric Ovarian Cancer, Clinical Characteristic, Histopathological Characteristic
Introduction/Background COVID-19 pandemic affects all fields, including gynaecology surgery, as 19% of deaths correlate with surgeries. This study aims to examine the effect of COVID-19 pandemic on gynaecological oncology surgery at
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.